WellmarkerBio Co.

PharmaceuticalsSeries CSeoul, South Koreawmbio.co

Latest round

Series C

Last raised

Aug 2021

Total raised

$56M

Investors

22

About WellmarkerBio Co.

, Ltd., Ltd. operates from its headquarters in Seoul, South Korea.WellmarkerBio specializes in the development of innovative cancer therapies through the use of predictive biomarkers. Their core offerings include First-in-Class oncology drugs designed to assess therapeutic efficacy before treatment.1 mn.WellmarkerBio plans to advance its product portfolio by launching new therapies designed for specific cancer types, although specific release dates are currently unavailable. The company aims to expand into additional markets beyond South Korea and the United States, focusing on regions where precision oncology is gaining traction.

Who invested in WellmarkerBio Co.

22 investors across 5 rounds

See all investors in WellmarkerBio Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Aug 28, 2021

    Amount

    $12M

    Investors

    Locked

  2. Series B

    Jul 6, 2019

    Amount

    $15M

    Investors

    Locked

  3. Series A

    Nov 1, 2018

    Amount

    $25M

    Investors

    Locked

  4. Seed

    Apr 3, 2018

    Amount

    $1.8M

    Investors

    Locked

  5. Seed

    Feb 20, 2018

    Amount

    $2.3M

    Investors

    Locked

Questions about WellmarkerBio Co.

Who invested in WellmarkerBio Co.?

WellmarkerBio Co. has 22 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has WellmarkerBio Co. raised?

WellmarkerBio Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did WellmarkerBio Co. last raise money?

WellmarkerBio Co.'s most recent round on record is a Series C, in Aug 2021.

What does WellmarkerBio Co. do?

WellmarkerBio Co. is a pharmaceuticals company.

Where is WellmarkerBio Co. headquartered?

WellmarkerBio Co. is headquartered in Seoul, South Korea.

Which VCs invest in companies like WellmarkerBio Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at WellmarkerBio Co.'s stage. Their profiles are linked below.

Raising like WellmarkerBio Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.